Back

Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?

European Heart Journal

23 June 2023
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes HEART FAILURE Acute Heart Failure Chronic Heart Failure BASIC SCIENCE

Contributors

Antonin Trimaille
Antonin Trimaille

Author

Benjamin Marchandot
Benjamin Marchandot

Author

University Hospital of Strasbourg Strasbourg , France

Olivier Morel
Olivier Morel

Author

University Hospital of Strasbourg Strasbourg , France

You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources